Michael Burgess

I guess my question really is, I am appreciative of trying to bring the technology into play and have it be helpful.

I am absolutely, adamantly opposed to the recreational use of marijuana.

And this is why we are very eager, particularly as we move toward much more expensive biotech drugs in the future to make sure that we are dealing with this problem up front because the problem that we have seen over the last 5 or 6 years…

As Congressman Burgess said million dollar drugs for various therapies start coming to market. We need a more rational way to do this.

We are on the cusp of some rather dramatic cures, not just treatments but cures, and this committee is responsible for the Cures for the 21st Century.

If we don't understand the difference between Sovaldi and Daraprim we may very get--come to the wrong conclusions here.

Giving a Member less than 24 hours to sign onto a piece of legislation they have never seen is discourteous.

Bipartisanship is asking for my input, not just for my vote.

It is likely that legislation to address drug pricing will ruffle some feathers, and that is OK.

I will admit to being frustrated that we are not considering, perhaps, some additional policies.

I mean, that is a gift to humanity.

It is not a good system that is being set up.

This is how those children get from Central America. They are brought by traffickers on the top of a train.

Moving the discounts to the point of sale, I have always said that the most immediate and most significant impact we can have on prescription drug pricing is to have transparency.

Prescription drug prices have been something that is extremely important to me and something that I have concentrated on.

We approved, and got signed into law, the first major sickle cell legislation, Danny Davis' bill from Illinois.

That accusation is false and it was made without this member, to the best of my knowledge, having ever visited an ORR facility.

I cannot imagine why people wouldn't want that system to not exist anymore.

I couldn't get anyone to accompany me.

The most immediate and most significant impact we can have on prescription drug pricing is to have transparency.

We heard in this committee two Congresses ago how there had not been a new FDA-approved treatment for sickle cell in almost 40 years.

Sometimes I feel like I am trapped in a Charles Dickens novel. It is the best of times; it is the worst of times.

You and your team have been responsive to our requests for information and input, and you have made yourself available to Members.

Under our Constitution, no money may be spent from the Treasury unless appropriated by Congress.

If Congress does not want you to undertake that task, Congress should change the law. It is up to you; it is up to us.